Reference : GC×GC-(HR)TOFMS in colorectal cancer metabolomics
Scientific congresses and symposiums : Unpublished conference/Abstract
Physical, chemical, mathematical & earth Sciences : Chemistry
http://hdl.handle.net/2268/233164
GC×GC-(HR)TOFMS in colorectal cancer metabolomics
English
Di Giovanni, Nicolas mailto [Université de Liège - ULiège > Département de chimie (sciences) > Chimie analytique, organique et biologique >]
Cojocariu, Cristian [Thermo Fisher Scientific > Runcorn, Cheshire, United Kingdom > > >]
Silcock, Paul [Thermo Fisher Scientific > Runcorn, Cheshire, United Kingdom > > >]
MEUWIS, Marie-Alice mailto [Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Recherche translationnelle en gastroentérologie >]
LOUIS, Edouard mailto [Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de gastroentérologie, hépatologie, onco. digestive >]
Focant, Jean-François mailto [Université de Liège - ULiège > Département de chimie (sciences) > Chimie analytique, organique et biologique >]
18-Dec-2018
Colorectal cancer globally affects more than one million new persons each year, and kills more than 700.000. Nevertheless, its diagnosis is still largely based on invasive tissue sampling and gaps remain in the understanding of its pathogenesis, with complex combinations between lifestyle, genetics, epigenetics, chronic inflammation (IBD) and microbiota. Untargeted metabolomics is one of the approaches that can be used to solve these issues.
To do so, an optimized and validated (NIST SRM 1950) comprehensive GC×GC-(HR)TOFMS method we developed was used, that also included an in-house QC system and data processing based on multiple statistical techniques.
Practically, we analyzed serum samples from patients affected by colorectal cancer (CRC, n = 18) and by colorectal cancer in remission (R-CRC, n = 17), and samples from healthy patients matched for biases (HC, n = 19 and R-HC, n = 17).
We highlighted candidate biomarkers able to discriminate between matched HC and CRC or R-CRC, which discrimination potential was assessed using supervised and unsupervised models, discriminant analysis and ROC curves. Overfitting was avoided by re-sampling and test validation testing.
Annotation used full mass spectrum, linear retention indices and accuracte mass provided by state-of-the-art high-resolution (HR) time-of-flight mass spectrometry. Finally, we studied the main metabolic pathways altered in the disease, whether in active or in remission state.
In addition, newly developed GC-MS Orbitrap was applied, using the same global method, to biological replicates to determine the capacity of this technology to perform in untargeted metabolomics as well as to validate the results previously obtained.
Yes
Yes
International
Metabomeeting 2018
18-20/12/2018
Metabolic Profiling Forum
Nottingham
United Kingdom
[en] Metabolomics ; GCxGC ; Colorectal cancer
[en] Colorectal cancer globally affects more than one million new persons each year, and kills more than 700.000. Nevertheless, its diagnosis is still largely based on invasive tissue sampling and gaps remain in the understanding of its pathogenesis, with complex combinations between lifestyle, genetics, epigenetics, chronic inflammation (IBD) and microbiota. Untargeted metabolomics is one of the approaches that can be used to solve these issues.
To do so, an optimized and validated (NIST SRM 1950) comprehensive GC×GC-(HR)TOFMS method we developed was used, that also included an in-house QC system and data processing based on multiple statistical techniques.
Practically, we analyzed serum samples from patients affected by colorectal cancer (CRC, n = 18) and by colorectal cancer in remission (R-CRC, n = 17), and samples from healthy patients matched for biases (HC, n = 19 and R-HC, n = 17).
We highlighted candidate biomarkers able to discriminate between matched HC and CRC or R-CRC, which discrimination potential was assessed using supervised and unsupervised models, discriminant analysis and ROC curves. Overfitting was avoided by re-sampling and test validation testing.
Annotation used full mass spectrum, linear retention indices and accuracte mass provided by state-of-the-art high-resolution (HR) time-of-flight mass spectrometry. Finally, we studied the main metabolic pathways altered in the disease, whether in active or in remission state.
In addition, newly developed GC-MS Orbitrap was applied, using the same global method, to biological replicates to determine the capacity of this technology to perform in untargeted metabolomics as well as to validate the results previously obtained.
Organic and Biological Analytical Chemistry Group, MS Lab
Researchers ; Professionals
http://hdl.handle.net/2268/233164

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Abstract 3 - Juin 2018 - CRC GCxGC (+ Orbi) - Version 250 mots.docxPublisher postprint14.39 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.